Netskope Inc
For the period ended Jul 31, 2026. Filed Sep 2, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jul 31, 2026 · Filed Sep 2, 2026
NTSK$21.44-4.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
(in thousands, except share and per share amounts)
| July 31, | January 31, | |
|---|---|---|
| 2026 | 2026 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $220,854 | $432,583 |
| Marketable securities | 846,509 | 725,603 |
| Accounts receivable, net | 187,971 | 158,278 |
| Inventories | 4,841 | 4,902 |
| Deferred contract acquisition costs | 58,387 | 54,048 |
| Prepaid expenses and other current assets | 67,723 | 73,553 |
| Total current assets | 1,386,285 | 1,448,967 |
| Property and equipment, net | 96,814 | 93,876 |
| Operating lease right-of-use assets | 32,262 | 32,096 |
| Intangible assets, net | 18,563 | 21,403 |
| Goodwill | 61,083 | 61,083 |
| Deferred contract acquisition costs, noncurrent | 106,037 | 100,798 |
| Other assets, noncurrent | 11,170 | 14,069 |
| Total assets | $1,712,214 | $1,772,292 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $25,929 | $14,436 |
| Accrued compensation and benefits | 76,646 | 99,880 |
| Deferred revenue | 546,462 | 532,732 |
| Operating lease liabilities, current | 10,229 | 10,769 |
| Accrued expenses and other current liabilities | 30,085 | 23,715 |
| Total current liabilities | 689,351 | 681,532 |
| Deferred revenue, noncurrent | 124,213 | 143,126 |
| Convertible notes | 698,116 | 720,960 |
| Operating lease liabilities, noncurrent | 23,887 | 23,424 |
| Other liabilities, noncurrent | 19,861 | 8,719 |
| Total liabilities | 1,555,428 | 1,577,761 |
| Commitments and contingencies (Note 7) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value; 300,000,000 shares authorized as of July 31, 2026 and January 31, 2026; no shares issued and outstanding as of July 31, 2026 and January 31, 2026 | - | - |
| Class A common stock, $0.0001 par value; 3,000,000,000 shares authorized as of July 31, 2026 and January 31, 2026; 265,409,308 shares issued and outstanding as of July 31, 2026 and 142,269,483 shares issued and outstanding as of January 31, 2026 | 6 | 6 |
| Class B common stock, $0.0001 par value; 600,000,000 shares authorized as of July 31, 2026 and January 31, 2026; 142,581,448 issued, and 142,555,841 outstanding as of July 31, 2026; 256,138,777 issued, and 256,113,170 outstanding as of January 31, 2026 | 35 | 34 |
| Class C common stock, $0.0001 par value; 1,000,000,000 shares authorized as of July 31, 2026 and January 31, 2026; no shares issued and outstanding as of July 31, 2026 and January 31, 2026 | - | - |
| Additional paid-in capital | 3,021,543 | 2,888,202 |
| Accumulated other comprehensive loss | (8,585) | (64,811) |
| Accumulated deficit | (2,856,213) | (2,628,900) |
| Total stockholders’ equity | 156,786 | 194,531 |
| Total liabilities and stockholders’ equity | $1,712,214 | $1,772,292 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.